Jiayuan Zhu

Jiayuan Zhu

Auto-generated profile, based on publicly available information

Jiayuan Zhu

Australian Institute of Bioengineering & Nanotechnology, The University of Queensland, Brisbane, Queensland 4072, Australia

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2025 in Science Advances
Verified
Journal Article
Open access
HFHelen Forgham
Helen Forgham
YCYixin Chang
Yixin Chang
YWYao Wang
Yao Wang
JZJiayuan Zhu
Jiayuan Zhu
LLLiwei Liu
Liwei Liu
Ruirui QiaoRuirui Qiao
Ruirui Qiao
The nanomedicine field continues to gain momentum, with several groundbreaking clinical trials underway. However, despite the promise of advanced antifouling nanoparticles incorporating poly(ethylene glycol)—a key component in the development of COVID-19 vaccines—the clinical translation of nanomedicine remains limited. This is primarily due to the relatively low delivery efficacy, with passive targeting relying on the enhanced permeability and retention effect, and active targeting leading to only modest improvements in target tissue accumulation. Improving the targeting, biocompatibility, and functionality of nanoparticles has the potential to create more effective, personalized, and minimally invasive therapies. This review aims to highlight the rise of a previously unidentified order of immune-minded nanomaterials and explores how mechanobiological principles and biomechanical nanotools are revolutionizing our understanding of nano-bio interactions in relation to disease. By considering mechanical properties such as stiffness, surface topology, and behavior under physiological flow conditions, researchers can better engineer nanoparticles for improved therapeutic outcomes.

22 April 2024 in Advanced Science
Verified
Journal Article
Open access
HFHelen Forgham
Helen Forgham
JZJiayuan Zhu
Jiayuan Zhu
XHXumin Huang
Xumin Huang
Cheng ZhangCheng Zhang
Cheng Zhang
HBHeather Biggs
Heather Biggs
Ruirui QiaoRuirui Qiao
Ruirui Qiao
Patients with brain cancers including medulloblastoma lack treatments that are effective long‐term and without side effects. In this study, a multifunctional fluoropolymer‐engineered iron oxide nanoparticle gene‐therapeutic platform is presented to overcome these challenges. The fluoropolymers are designed and synthesized to incorporate various properties including robust anchoring moieties for efficient surface coating, cationic components to facilitate short interference RNA (siRNA) binding, and a fluorinated tail to ensure stability in serum. The blood‐brain barrier (BBB) tailored system demonstrates enhanced BBB penetration, facilitates delivery of functionally active siRNA to medulloblastoma cells, and delivers a significant, almost complete block in protein expression within an in vitro extracellular acidic environment (pH 6.7) – as favored by most cancer cells. In vivo, it effectively crosses an intact BBB, provides contrast for magnetic resonance imaging (MRI), and delivers siRNA capable of slowing tumor growth without causing signs of toxicity – meaning it possesses a safe theranostic function. The pioneering methodology applied shows significant promise in the advancement of brain and tumor microenvironment‐focused MRI‐siRNA theranostics for the better treatment and diagnosis of medulloblastoma.

9 April 2024 in Nanomedicine
Verified
Journal Article
Open access
HFHelen Forgham
Helen Forgham
JZJiayuan Zhu
Jiayuan Zhu
TZTaoran Zhang
Taoran Zhang
XHXumin Huang
Xumin Huang
XLXiangke Li
Xiangke Li
Ruirui QiaoRuirui Qiao
Ruirui Qiao
Aim: To investigate the influence of fluorine in reducing the adsorption of immune-reactive proteins onto PEGylated gold nanoparticles. Methods: Reversible addition fragmentation chain transfer pol... Plain language summary Nanomedicines are based around the delivery of therapies by tiny, nanosized delivery vehicles. This method offers a much better way of specifically targeting life-threatening... Tweetable abstract Fluorine-modified polymer coatings on gold nanoparticles exhibit greater antifouling effects against complement and other immunogenic proteins found in the blood.

20 April 2023 in Coordination Chemistry Reviews
Verified
Journal Article
Closed access
HFHelen Forgham
Helen Forgham
LLLiwei Liu
Liwei Liu
JZJiayuan Zhu
Jiayuan Zhu
IJIbrahim Javed
Ibrahim Javed
WCWeibo Cai
Weibo Cai
TDThomas P. Davis
Thomas P. Davis

15 January 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
HFHelen Forgham
Helen Forgham
EAEduardo A. Albornoz
Eduardo A. Albornoz
GPGiovanni Pietrogrande
Giovanni Pietrogrande
JZJiayuan Zhu
Jiayuan Zhu
KCKa Hang Karen Chung
Ka Hang Karen Chung
IJIbrahim Javed
Ibrahim Javed
Gut bacteria have emerged as silent drivers in the pathology of Alzheimer’s disease (AD). They also make amyloids with structure analogue to pathological amyloids and have potential to cross-seed and propagate in a prion-like manner. AD is characterised by the accumulation of mature extracellular Amyloid-β (Aβ) plaques which are surrounded by inflammatory microglia. We report that exposure to interspecies microbial amyloids of FapC (fimbriae) and CsgA (curli) from opportunistic gut pathogens Pseudomonas aeruginosa and Escherichia coli hyperactivates microglia against Aβ fibrils. Microbial amyloids and Aβ fibrils converge in phagocytic compartments through subsequent internalization, not observed with Aβ fibrils alone. This convergence promotes pro-inflammatory microglia with a defective proteome similar to those observed in AD brains. The resulting clusters develop a pro-inflammatory, indigestible interactome that is eventually regurgitated, inducing progressive degeneration in bystander neurons and ultimately leading to cognitive decline. Collectively, these findings provide compelling evidence that microbial amyloids can trigger progressive AD pathology through microglia-driven neuroinflammation.

10 November 2022
Verified
Conference Paper
Closed access
PDF file
HDHaozhong Dong
Haozhong Dong
QLQizhou Li
Qizhou Li
JZJiayuan Zhu
Jiayuan Zhu
The high energetic particle generated from nuclear fusion will severely change material structures and properties of the reactor, where the surface of the steering gear would become fluffy. On this basis, the SRIM software is introduced in this paper, aiming to investigate the impact of different ions with different masses and energies on material structures in order to observe the damage on the material caused by the radiation. According to our simulation, a drop in 13% elastic property has been observed. The bombardment can produce a considerable amount of damage, which should be taken into consideration during the design. Thus, the tungsten shield can’t be used as weight supporting element. Besides, regarding the above discussion, a wider margin should be taken into consider when designing the fusion reactor. We hope to figure out some uncontrollable error and imperfection still existing in the simulation. These results offer a guideline for better observation of the damage on the material caused by the radiation.